Sonavex

About:

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

Website: http://www.sonavex.com

Twitter/X: sonavex

Top Investors: National Science Foundation, Gaingels, TEDCO, National Institutes of Health, Keiretsu Capital

Description:

Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.

Total Funding Amount:

$33M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2013-01-01

Contact Email:

contact(AT)sonavex.com

Founders:

David Narrow, Devin Coon

Number of Employees:

1-10

Last Funding Date:

2024-10-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai